Shrujal Baxi currently serves as a medical director at Flatiron Health, where she focuses on real-world evidence generation. In addition to active involvement in therapeutic clinical trials, Shrujal has used large national cancer registry data to investigate practice patterns in oncology. In addition, she has published on the non-oncologic outcomes associated with cancer including toxicities of treatment. In response to findings, she investigated systems-level solutions to facilitate delivery of comprehensive survivorship care.
Shrujal simultaneously received her medical degree and her masters in public health with an emphasis on health policy and administration, both from the University of Illinois. She then completed residency at New York University. After serving as a chief resident, she completed a fellowship in medical oncology at Memorial Sloan Kettering Cancer Center and joined their faculty in 2011, where she specialized in cancers of the head and neck, salivary glands, and thyroid along with non-melanoma cutaneous malignancies.
|9:55 AM - 10:20 AM||
Real-World Evidence and AI: Where are We Now and How Can We Take the Next Steps Forward to Directly Impact Care?
This session will focus on the kind of real world data that is needed to realize the potential of AI. With so much opportunity for progress, prioritizing projects is a critical step in delivering on results. Speakers will help identify what types of questions are easier to answer and which are harder in order to help you choose the projects that will result in near term ROI. Using case study examples from two therapeutic areas, discussion will cover these questions and more: